Please login to the form below

Not currently logged in
Email:
Password:

New accounts: February

The following table lists new pharmaceutical account wins notified to us by the winning agencies for the period November 2005 to January 2006 inclusive

The following table lists new pharmaceutical account wins notified to us by the winning agencies for the period November 2005 to January 2006 inclusive. Please note that inclusion in this table does not necessarily indicate exclusivity and other agencies may also be involved with some of the products listed in other ways, or in domestic, overseas or international markets.

To submit an entry for New Accounts, email nhobson@pmlive.com

Astellas

Pan-European corporate profiling

Corporate

The Choice Group

Boehringer Ingelheim/Lilly UK

Cymbalta

Neurology

Virgo Health PR

Cephalon

Actiq

Pain

TVF Communications

Novartis

Aclasta

CRM

MRM Worldwide

Novartis

Prexige

Osteoarthritic pain

Clew Communications

Novartis

Transplantation portfolio

Transplantation

LeapFrog Medical

Pfizer

Diovan/Codiovan

Hypertension

TVF Communications

Pfizer

Injectable contraceptive

Contraception

Ruder Finn

Roche

Avastin

Oncology

Ketchum

Solvay

Omacor

Cardiology

LeapFrog Medical

UCB Pharma

Equasym XL

ADHD

TVF Communications

2nd September 2008

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
infill healthcare communication

infill is a dynamic and innovative, international healthcare agency with >25 years' experience in delivering healthcare communication, medical education and...

Latest intelligence

AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...
Combined immunotherapies – potential and pitfalls
‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...

Infographics